{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T04:45:44Z","timestamp":1788929144150,"version":"build-2803163510"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","award":["NCT00996164"],"award-info":[{"award-number":["NCT00996164"]}],"id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,7,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Hypoactive Sexual Desire Disorder (HSDD) is characterized by low sexual desire that causes marked distress or interpersonal difficulty.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>The aim of this study was to assess the efficacy and safety of the 5-HT1A agonist\/5-HT2A antagonist flibanserin in premenopausal women with HSDD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This was a randomized, placebo-controlled trial in which premenopausal women with HSDD (mean age: 36.6 years) were treated with flibanserin 100\u2009mg once daily at bedtime (qhs) (n\u2009=\u2009542) or placebo (n\u2009=\u2009545) for 24 weeks.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Outcome Measures<\/jats:title>\n                    <jats:p>Coprimary end points were the change from baseline to study end in Female Sexual Function Index (FSFI) desire domain score and in number of satisfying sexual events (SSE) over 28 days. Secondary end points included the change from baseline in FSFI total score, Female Sexual Distress Scale-Revised (FSDS-R) total score, and FSDS-R Item 13 score.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Compared with placebo, flibanserin led to increases in mean (standard deviation) SSE of 2.5 (4.6) vs. 1.5 (4.5), mean (standard error [SE]) FSFI desire domain score of 1.0 (0.1) vs. 0.7 (0.1), and mean (SE) FSFI total score of 5.3 (0.3) vs. 3.5 (0.3); and decreases in mean (SE) FSDS-R Item 13 score of \u22121.0 (0.1) vs. \u22120.7 (0.1) and mean (SE) FSDS-R total score of \u22129.4 (0.6) vs. \u22126.1 (0.6); all P\u2009\u2264\u20090.0001. The most frequently reported adverse events in the flibanserin group were somnolence, dizziness, and nausea, with adverse events leading to discontinuation in 9.6% of women receiving flibanserin vs. 3.7% on placebo.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In premenopausal women with HSDD, flibanserin 100\u2009mg qhs resulted in significant improvements in the number of SSE and sexual desire (FSFI desire domain score) vs. placebo. Flibanserin was associated with significant reductions in distress associated with sexual dysfunction (FSDS-R total score) and distress associated with low sexual desire (FSDS-R Item 13) vs. placebo. There were no significant safety concerns associated with the use of flibanserin for 24 weeks.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/jsm.12189","type":"journal-article","created":{"date-parts":[[2013,5,14]],"date-time":"2013-05-14T09:48:48Z","timestamp":1368524928000},"page":"1807-1815","source":"Crossref","is-referenced-by-count":147,"title":["Efficacy of Flibanserin in Women with Hypoactive Sexual Desire Disorder: Results from the BEGONIA Trial"],"prefix":"10.1093","volume":"10","author":[{"given":"Molly","family":"Katz","sequence":"first","affiliation":[{"name":"Katz and Kade , Cincinnati, OH , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard R.","family":"DeRogatis","sequence":"additional","affiliation":[{"name":"Center for Sexual Medicine at Sheppard Pratt , Baltimore, MD , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Ackerman","sequence":"additional","affiliation":[{"name":"Comprehensive Clinical Trials, LLC , West Palm Beach, FL , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parke","family":"Hedges","sequence":"additional","affiliation":[{"name":"Clinical Trials of Texas, Inc. , San Antonio, TX , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynna","family":"Lesko","sequence":"additional","affiliation":[{"name":"Windwood Pharma Consulting , South Kent, CT , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Miguel","family":"Garcia","sequence":"additional","affiliation":[{"name":"Boehringer Ingelheim , Ridgefield, CT , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Sand","sequence":"additional","affiliation":[{"name":"Boehringer Ingelheim , Ridgefield, CT , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,7,1]]},"reference":[{"key":"2024032601003889100_bb0010","article-title":"Diagnostic and statistical manual of mental disorders","year":"2000"},{"key":"2024032601003889100_bb0015","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1743-6109.2009.01619.x","article-title":"Recommendations for the clinical evaluation of men and women with sexual dysfunction","volume":"7","author":"Hatzichristou","year":"2010","journal-title":"J Sex Med"},{"key":"2024032601003889100_bb0020","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1111\/j.1743-6109.2009.01252.x","article-title":"Correlates of sexually related personal distress in women with low sexual desire","volume":"6","author":"Rosen","year":"2009","journal-title":"J Sex Med"},{"key":"2024032601003889100_bb0025","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1097\/AOG.0b013e3181898cdb","article-title":"Sexual problems and distress in United States women: Prevalence and correlates","volume":"112","author":"Shifren","year":"2008","journal-title":"Obstet Gynecol"},{"key":"2024032601003889100_bb0030","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/00224490902747222","article-title":"The dual control model: Current status and future directions","volume":"46","author":"Bancroft","year":"2009","journal-title":"J Sex Res"},{"key":"2024032601003889100_bb0035","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1111\/j.1743-6109.2009.01309.x","article-title":"Pathways of sexual desire","volume":"6","author":"Pfaus","year":"2009","journal-title":"J Sex Med"},{"key":"2024032601003889100_bb0040","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1527-3458.2002.tb00219.x","article-title":"Pharmacology of flibanserin","volume":"8","author":"Borsini","year":"2002","journal-title":"CNS Drug Rev"},{"key":"2024032601003889100_bb0045","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1111\/j.1743-6109.2010.01763.x","article-title":"Acute and repeated flibanserin administration in female rats modulates monoamines differentially across brain areas: A microdialysis study","volume":"7","author":"Allers","year":"2010","journal-title":"J Sex Med"},{"key":"2024032601003889100_bb0050","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1743-6109.2010.02032.x","article-title":"Multifunctional pharmacology of flibanserin: Possible mechanism of therapeutic action in hypoactive sexual desire disorder","volume":"8","author":"Stahl","year":"2011","journal-title":"J Sex Med"},{"key":"2024032601003889100_bb0055","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1017\/S1461145702002869","article-title":"Region-dependent effects of flibanserin and buspirone on adenylyl cyclase activity in the human brain","volume":"5","author":"Marazziti","year":"2002","journal-title":"Int J Neuropsychopharmacol"},{"key":"2024032601003889100_bb0060","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/j.1743-6109.2011.02595.x","article-title":"Treatment of hypoactive sexual desire disorder in premenopausal women: Efficacy of flibanserin in the DAISY study","volume":"9","author":"Thorp","year":"2012","journal-title":"J Sex Med"},{"key":"2024032601003889100_bb0065","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/j.1743-6109.2011.02626.x","article-title":"Treatment of hypoactive sexual desire disorder in premenopausal women: Efficacy of flibanserin in the VIOLET study","volume":"9","author":"DeRogatis","year":"2012","journal-title":"J Sex Med"},{"key":"2024032601003889100_bb0070","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1743-6109.2009.01628.x","article-title":"Standards for clinical trials in sexual dysfunction in women: Research designs and outcomes assessment","volume":"7","author":"Clayton","year":"2010","journal-title":"J Sex Med"},{"key":"2024032601003889100_bb0075","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1111\/j.1743-6109.2011.02312.x","article-title":"Content validity of the Female Sexual Function Index (FSFI) in pre- and postmenopausal women with hypoactive sexual desire disorder","volume":"8","author":"Revicki","year":"2011","journal-title":"J Sex Med"},{"key":"2024032601003889100_bb0080","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1080\/cmt.4.4.267.272","article-title":"Executive summary: Stages of Reproductive Aging Workshop (STRAW)","volume":"4","author":"Soules","year":"2001","journal-title":"Climacteric"},{"key":"2024032601003889100_bb0085","first-page":"1","article-title":"Beck depression inventory: Manual","author":"Beck","year":"1996"},{"key":"2024032601003889100_bb0090","volume-title":"State of the science: measurement of suicidal adverse events and the Columbia Suicide Severity Rating Scale","author":"Posner","year":"2007"},{"key":"2024032601003889100_bb0095","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/009262300278597","article-title":"The Female Sexual Function Index (FSFI): A multidimensional self-report instrument for the assessment of female sexual function","volume":"26","author":"Rosen","year":"2000","journal-title":"J Sex Marital Ther"},{"key":"2024032601003889100_bb0100","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1743-6109.2007.00672.x","article-title":"Validation of the Female Sexual Distress Scale-Revised for assessing distress in women with hypoactive sexual desire disorder","volume":"5","author":"DeRogatis","year":"2008","journal-title":"J Sex Med"},{"key":"2024032601003889100_bb0105","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2217\/WHE.10.54","article-title":"Flibanserin: A potential treatment for hypoactive sexual desire disorder in premenopausal women","volume":"6","author":"Clayton","year":"2010","journal-title":"Womens Health (Lond Engl)"},{"key":"2024032601003889100_bb0110","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/713847100","article-title":"Validation of the Female Sexual Function Index (FSFI) in women with female orgasmic disorder and in women with hypoactive sexual desire disorder","volume":"29","author":"Meston","year":"2003","journal-title":"J Sex Marital Ther"},{"key":"2024032601003889100_bb0115","first-page":"153","article-title":"Do shorter recall periods provide better assessment of desire in women with hypoactive sexual desire disorder?","volume":"8","author":"Katz","year":"2011","journal-title":"J Sex Med"},{"key":"2024032601003889100_bb0120","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1111\/j.1743-6109.2011.02385.x","article-title":"Does the Female Sexual Distress Scale-Revised cover the feelings of women with HSDD?","volume":"8","author":"DeRogatis","year":"2011","journal-title":"J Sex Med"},{"key":"2024032601003889100_bb0125","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1111\/j.1743-6109.2012.02942.x","article-title":"Open-label extension study of flibanserin in women with hypoactive sexual desire disorder","volume":"9","author":"Jayne","year":"2012","journal-title":"J Sex Med"},{"key":"2024032601003889100_bb0130","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1111\/j.1743-6109.2011.02458.x","article-title":"Continued efficacy and safety of flibanserin in premenopausal women with hypoactive sexual desire disorder (HSDD): Results from a randomized withdrawal trial","volume":"8","author":"Goldfischer","year":"2011","journal-title":"J Sex Med"},{"key":"2024032601003889100_bb0135","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2165\/11319480-000000000-00000","article-title":"Safety reporting and adverse event profile of mirtazapine described in randomized controlled trials in comparison with other classes of antidepressants in the acute-phase treatment of adults with depression: Systematic review and meta-analysis","volume":"24","author":"Watanabe","year":"2010","journal-title":"CNS Drugs"},{"key":"2024032601003889100_bb0140","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0140-6736(99)11381-3","article-title":"SNaRIs, NaSSAs, and NaRIs: New agents for the treatment of depression","volume":"355","author":"Kent","year":"2000","journal-title":"Lancet"},{"key":"2024032601003889100_bb0145","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/gme.0b013e318230e286","article-title":"Characteristics of premenopausal and postmenopausal women with acquired, generalized hypoactive sexual desire disorder: The Hypoactive Sexual Desire Disorder Registry for women","volume":"19","author":"Rosen","year":"2012","journal-title":"Menopause"},{"key":"2024032601003889100_bb0150","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.4088\/JCP.09m05390gry","article-title":"Distressing sexual problems in United States women revisted: Prevalence after accounting for depression","volume":"70","author":"Johannes","year":"2009","journal-title":"J Clin Psychiatry"},{"issue":"suppl 6","key":"2024032601003889100_bb0155","first-page":"33","article-title":"Major depressive disorder, antidepressants, and sexual dysfunction","volume":"67","author":"Clayton","year":"2006","journal-title":"J Clin Psychiatry"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515304136?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515304136?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/10\/7\/1807\/48192277\/jsm_10_7_1807.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/10\/7\/1807\/48192277\/jsm_10_7_1807.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T21:49:50Z","timestamp":1711403390000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/10\/7\/1807\/6939988"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,1]]},"references-count":30,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2013,7,1]]},"published-print":{"date-parts":[[2013,7,1]]}},"URL":"https:\/\/doi.org\/10.1111\/jsm.12189","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718010378.793478100","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.718010378.793478106","asserted-by":"object"}]},"ISSN":["1743-6109","1743-6095"],"issn-type":[{"value":"1743-6109","type":"electronic"},{"value":"1743-6095","type":"print"}],"subject":[],"published-other":{"date-parts":[[2013,7]]},"published":{"date-parts":[[2013,7,1]]}}}